An evaluation of avutometinib in combination with defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer.
Saved in:
| Title: | An evaluation of avutometinib in combination with defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer. |
|---|---|
| Authors: | Podder V; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA., Slomovitz BM; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA., Coleman RL; Texas Oncology, US Oncology Network, Georgetown, TX, USA. |
| Source: | Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2026 May 03, pp. 1-14. Date of Electronic Publication: 2026 May 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
